Type 2 Diabetes Mellitus (T2DM) continues to grow rapidly across India, affecting millions of people and increasing the burden of cardiovascular and renal complications. Modern diabetic management demands safer, faster, and more effective glucose control—without compromising patient comfort or long-term organ health.

GLIEMPAFLOZIN LINA 10 mg/5 mg, developed by Steris Healthcare Pvt. Ltd., is a cutting-edge dual-action anti-diabetic formulation combining Empagliflozin (10 mg) and Linagliptin (5 mg). This fixed-dose combination is designed to deliver comprehensive glucose regulation, reduce HbA1c, support weight management, and offer additional cardiovascular and renal protection.

Its unique mechanism makes it suitable for Indian diabetic patients who demand fast results, minimal side effects, and enhanced quality of life.

What Is GLIEMPAFLOZIN LINA 10 mg/5 mg?

GLIEMPAFLOZIN LINA is an advanced oral antidiabetic combination containing:

• Empagliflozin 10 mg – SGLT2 inhibitor

• Linagliptin 5 mg – DPP-4 inhibitor

Together, they provide dual-pathway glucose control:

• Empagliflozin promotes glucose excretion via urine

• Linagliptin enhances natural insulin secretion

This combination helps reduce fasting blood glucose (FBG), post-prandial blood glucose (PPBG), and HbA1c levels efficiently.

Composition

Each tablet of GLIEMPAFLOZIN LINA 10 mg/5 mg contains:

• Empagliflozin 10 mg

• Linagliptin 5 mg

• Pharmaceutical excipients for stability, enhanced absorption, and better tolerance

How It Works – Dual Mechanism for Superior Glycemic Control

1. Empagliflozin – SGLT2 Inhibitor

• Blocks the SGLT2 protein in kidneys

• Prevents glucose reabsorption

• Promotes glucose elimination through urine

• Helps lower blood sugar naturally

• Supports weight reduction

• Lowers blood pressure

• Proven to reduce cardiovascular death risk in high-risk patients

2. Linagliptin – DPP-4 Inhibitor

• Increases incretin hormone levels

• Enhances insulin release after meals

• Suppresses excess glucagon

• Supports pancreatic beta-cell function

• Minimal risk of hypoglycemia

Together, they deliver powerful, safe, and long-lasting glucose control.

Uses of GLIEMPAFLOZIN LINA 10 mg/5 mg

This combination is widely used for the management of:

1. Type 2 Diabetes Mellitus

Helps maintain stable blood sugar levels throughout the day.

2. High HbA1c Levels

Recommended for patients not achieving adequate control with monotherapy.

3. Overweight or Obese Diabetic Patients

Empagliflozin aids in fat loss and reduces visceral fat.

4. Cardiovascular Risk Reduction

Empagliflozin has proven benefits in reducing heart-related mortality.

5. Diabetic Kidney Health Support

Helps reduce progression of kidney diseases in diabetes.

Benefits of GLIEMPAFLOZIN LINA 10 mg/5 mg

1. Dual-Action Formula for Powerful Glucose Control

Targets glucose through two independent pathways, ensuring broader and more effective blood sugar management.

2. Reduced HbA1c Levels

Clinically proven to lower HbA1c faster and more effectively than single-agent therapy.

3. Weight Loss & Better Metabolic Health

• Empagliflozin promotes natural calorie loss

• Helps reduce body weight and waist circumference

4. Low Risk of Hypoglycemia

Safe for daily use even in elderly diabetic patients.

5. Heart and Kidney Protection

A major advantage for Indian diabetic patients who are at higher risk of heart diseases.

6. Good Tolerability

Minimal gastrointestinal or systemic side effects.

7. Convenient Once-Daily Tablet

Improves compliance, making it ideal for long-term diabetic control.

Dosage & Administration

Recommended Dose

• One tablet daily, taken with or without food

• Preferably at the same time each day

Important Instructions

• Do not crush or chew

• Ensure adequate hydration

• Follow diet and lifestyle recommendations

Note: Dosage adjustments should be guided by a registered physician depending on renal health, HbA1c levels, and other medications.

Side Effects

GLIEMPAFLOZIN LINA is generally well tolerated, but some patients may experience:

Common Side Effects

• Increased urination

• Thirst

• Mild urinary tract infections

• Nasal congestion

• Headache

Less Common but Important Side Effects

• Genital infections

• Hypoglycemia (if used with sulfonylureas or insulin)

Seek medical advice if symptoms persist or worsen.

Precautions and Warnings

• Not recommended for Type 1 diabetes

• Avoid in severe renal impairment

• Not suitable during pregnancy or breastfeeding

• Inform doctor before use if on diuretics or blood pressure medications

• Maintain proper hygiene to avoid UTI or genital infections

Who Should Use GLIEMPAFLOZIN LINA?

Ideal for patients:

• With uncontrolled blood sugar despite monotherapy

• Having high cardiovascular risk

• Suffering from obesity or metabolic syndrome

• Wanting weight reduction along with diabetes control

• Seeking safe and modern diabetes management

Who Should Avoid It?

• Patients with severe kidney disease

• Pregnant or lactating women

• People with a history of recurrent UTIs

• Type 1 diabetes patients

• Patients with diabetic ketoacidosis

Lifestyle Tips to Enhance Results

To maximize the benefits of GLIEMPAFLOZIN LINA:

1. Adopt a carbohydrate-controlled diet

2. Exercise regularly for 30–45 minutes

3. Maintain hydration

4. Avoid smoking and alcohol

5. Monitor blood sugar regularly

6. Follow up with your physician

Conclusion

GLIEMPAFLOZIN LINA 10 mg/5 mg is a scientifically advanced, highly effective, and patient-friendly formulation that provides robust control over Type 2 Diabetes. With its dual-mechanism approach, it not only lowers blood sugar levels but also offers significant additional benefits, including weight loss, heart protection, kidney support, and improved overall metabolic health.